AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimiwin M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Docwin Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimiwin M 1mg/500mg Tablet

Diabetic patients using Glimepiride/Metformin 1mg/500mg tablets should understand that this anti-diabetic medication combines two active ingredients to manage type 2 diabetes in adults. It effectively regulates blood glucose, but consistent daily use, at the same time each day with food, as directed by your physician, is crucial for optimal results. Dosage adjustments are common, based on your blood sugar response. Discontinuing this medication without medical supervision is dangerous, potentially leading to elevated blood sugar and serious complications such as kidney damage, vision impairment, neuropathy, and limb loss. This medication is part of a broader management plan that necessitates a healthy diet, physical activity, and weight management, as advised by your doctor. Common side effects include hypoglycemia (low blood sugar), manifesting as sweating, dizziness, headache, and tremors. Learn to recognize these symptoms and carry a fast-acting sugar source. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects are altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Individuals with a history of heart disease should consult their doctor before initiating treatment. Pregnant or breastfeeding women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood counts and liver function are recommended.

Uses of Glimiwin M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimiwin M 1mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glimiwin M 1mg/500mg Tablet should be administered with a meal.

Common Side effects of Glimiwin M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimiwin M 1mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimiwin M 1mg/500mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

How Glimiwin M 1mg/500mg Tablet works:

Glimiwin M, a 1mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimiwin M 1mg/500mg tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimiwin M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimiwin M 1mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when prescribing Glimiwin M 1mg/500mg tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. The use of Glimiwin M 1mg/500mg tablets is contraindicated in patients experiencing severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimiwin M 1mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; it's contraindicated in patients with severe liver disease.

What if you forget to take Glimiwin M 1mg/500mg Tablet :

Should you forget a Glimiwin M 1mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimiwin M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimiwin M 1mg/500mg Tablet

Store this medication in its original, tightly closed container as directed on the label. Dispose of any unused medication safely and prevent access by children, pets, and others.
Glimiwin M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but dangerous side effect is more likely in individuals with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue use and seek immediate medical attention.
Glimiwin M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Glimiwin M 1mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimiwin M 1mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplementation with external vitamin B12 sources is recommended by some researchers.
Glimiwin M 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), resulting in symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimiwin M 1mg/500mg Tablet with alcohol is unsafe. Alcohol can exacerbate the drug's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimiwin M 1mg/500mg Tabl...
62
MRP 75
17% off